Abstract:The cardiovascular effects of midazolam 0.2 mg kg-1 i.v. were studied during the induction of anaesthesia in 16 premedicated patients subjected to cardiac surgery. In eight patients with coronary artery disease in whom global resting left ventricular function was normal the haemodynamic changes were small and observations on arterial pressure, cardiac index, stroke index, cardiac filling pressures, systemic and pulmonary vascular resistance appeared to parallel those accompanying deep sleep in healthy voluntee… Show more
“…16 W. HESS et al reported that Midazolam can be used as a valuable alternative to conventional induction agents in cardiac surgical patients without adverse effects on the cardiovascular system. 17 The results we obtained from our study revealed no significant differences in the efficacies of the two drugs and neither caused major alterations in the haemodynamic variables. However, hypotension after induction was observed with Midazolam in few cases which may possibly be due to reduction of sympathetic activity causing vasodilatation and/or interference with the transmembrane influx of Ca 2+ and its enhancement of NO synthesis from endothelial vascular smooth muscles.…”
Section: Discussionmentioning
confidence: 45%
“…However, hypotension after induction was observed with Midazolam in few cases which may possibly be due to reduction of sympathetic activity causing vasodilatation and/or interference with the transmembrane influx of Ca 2+ and its enhancement of NO synthesis from endothelial vascular smooth muscles. 17,18 Pain on injection and myoclonus were observed only with Etomidate. Miner et al also concluded high incidence of myoclonus (20%) with Etomidate.…”
Background: Induction and endotracheal intubation are invariably associated with certain cardiovascular changes during anaesthesia practice and can lead to sudden swings of blood pressure, arrhythmias, MI and cardiovascular collapse especially in geriatric and haemodynamically unstable patients. Therefore it is desirable to use a safer agent with fewer adverse effects to minimise these complications. Present prospective randomized study is designed to compare the haemodynamic alterations and various adverse effects following induction with etomidate and midazolam.Methods: Hundred ASA I and II patients of age group 18-60 years scheduled for elective surgical procedure under general anesthesia were randomly divided into two groups of 50 each receiving etomidate (0.3mg/kg) and midazolam (0.15mgk/kg) as an induction agent. Vital parameters before and after induction and thereafter at specified time interval following laryngoscopy and intubation were recorded for comparison. Adverse effect viz. pain on injection, apnea and myoclonic activity were also carefully watched.Results: Demographic variables in both the groups were comparable. Patients in both the groups showed little change in mean arterial pressure (MAP) and heart rate (HR) from baseline value (p >0.05). Pain on injection and myoclonic activity were seen in etomidate group while delayed awakening was seen with Midazolam group.Conclusions: This study concludes that both etomidate and midazolam provides haemodynamic stability but Midazolam can be preferred as an induction agent in view of fewer side effects.
“…16 W. HESS et al reported that Midazolam can be used as a valuable alternative to conventional induction agents in cardiac surgical patients without adverse effects on the cardiovascular system. 17 The results we obtained from our study revealed no significant differences in the efficacies of the two drugs and neither caused major alterations in the haemodynamic variables. However, hypotension after induction was observed with Midazolam in few cases which may possibly be due to reduction of sympathetic activity causing vasodilatation and/or interference with the transmembrane influx of Ca 2+ and its enhancement of NO synthesis from endothelial vascular smooth muscles.…”
Section: Discussionmentioning
confidence: 45%
“…However, hypotension after induction was observed with Midazolam in few cases which may possibly be due to reduction of sympathetic activity causing vasodilatation and/or interference with the transmembrane influx of Ca 2+ and its enhancement of NO synthesis from endothelial vascular smooth muscles. 17,18 Pain on injection and myoclonus were observed only with Etomidate. Miner et al also concluded high incidence of myoclonus (20%) with Etomidate.…”
Background: Induction and endotracheal intubation are invariably associated with certain cardiovascular changes during anaesthesia practice and can lead to sudden swings of blood pressure, arrhythmias, MI and cardiovascular collapse especially in geriatric and haemodynamically unstable patients. Therefore it is desirable to use a safer agent with fewer adverse effects to minimise these complications. Present prospective randomized study is designed to compare the haemodynamic alterations and various adverse effects following induction with etomidate and midazolam.Methods: Hundred ASA I and II patients of age group 18-60 years scheduled for elective surgical procedure under general anesthesia were randomly divided into two groups of 50 each receiving etomidate (0.3mg/kg) and midazolam (0.15mgk/kg) as an induction agent. Vital parameters before and after induction and thereafter at specified time interval following laryngoscopy and intubation were recorded for comparison. Adverse effect viz. pain on injection, apnea and myoclonic activity were also carefully watched.Results: Demographic variables in both the groups were comparable. Patients in both the groups showed little change in mean arterial pressure (MAP) and heart rate (HR) from baseline value (p >0.05). Pain on injection and myoclonic activity were seen in etomidate group while delayed awakening was seen with Midazolam group.Conclusions: This study concludes that both etomidate and midazolam provides haemodynamic stability but Midazolam can be preferred as an induction agent in view of fewer side effects.
“…Peptic ulceration, intestinal ischaemia and sepsis have all been reported [4][5][6][7], and in patients undergoing operations under cardiopulmonary bypass, local hypoperfusion of the splanchnic region has been found to result in decreased oxygen extraction and to an increase in serum lactate levels [8][9][10]. Induction of general anaesthesia will further augment this redistribution of circulating volume [11].…”
SummarySurgical patients develop a fluid deficit during pre-operative starvation. This study examines the effects of pre-operative fluid administration on haemodynamic variables, oxygenation and splanchnic perfusion in patients undergoing elective coronary artery bypass grafting. Forty-eight patients were randomised to receive either a pre-operative crystalloid infusion (crystalloid group, n ¼ 24) or no infusion (control group, n ¼ 24). Patients in the crystalloid group received a continuous infusion of Ringer's solution at 1.5 ml.kg )1 .h )1 from 22:00 h until induction of anaesthesia the next morning. Immediately before induction of anaesthesia, all patients were given a colloid infusion to increase pulmonary capillary wedge pressure and central venous pressure to similar levels in both groups. Haemodynamic and oxygenation parameters were measured using invasive cardiovascular monitoring, and splanchnic perfusion was assessed by indocyanine green clearance. Patients in the crystalloid group received a mean (SD) of 1008 (140) ml of Ringer's solution overnight. Patients in the crystalloid group had a higher splanchnic blood flow than the control group before induction of anaesthesia [mean (SD) ¼ 1782 (573) ml.min )1 vs. 1391 (333) ml.min )1 , p < 0.05]. There were no significant differences in systemic haemodynamic data and global oxygenation parameters between the two groups. Pre-operative infusion of crystalloid appears to result in an improvement in pre-operative splanchnic perfusion.
“…Both SBP and DBP decreased in midazolam group compared to the control and G-CSF groups at the fourhour time point. The difference among the groups may be due to the fact that midazolam can dilate the smooth muscle artery and decrease systematical circulation resistance (16,17). Another reason for this difference is that the depth of anesthesia decreased because of continuous infusion of sodium chloride without any sedation effect, so the BP and HR in the control and G-CSF groups increased after the four-hour time point compared to the midazolam group.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.